TSX Venture 50 Badge TSX Venture 50 Badge 329% share price appreciation in 2025Company expects strong shareholder value drivers in 2026 TORONTO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cerrado Gold Inc. [TSX.V: CERT][OTCQX: CRDOF] (“Cerrado” or the “Company”) is pleased to announce that it has been recognized as one of the 2026 top 50 performers on the TSX Venture Exchange (“TSXV”), based on an outstanding 329% (C$1.61) share price appreciation and 460% (C$183mm) market capitalization growth for the period of ...

Core Viewpoint - Certara, Inc. (NASDAQ:CERT) is identified as an oversold value stock with significant upside potential, supported by analyst confidence and recent upgrades despite sector volatility [1][2][3][4]. Group 1: Analyst Sentiment - As of February 5, 2026, 60% of analysts maintain a bullish outlook on Certara, with a consensus price target of $12.00, indicating a 57.70% upside potential [2]. - KeyBanc reduced its price target from $13 to $12 but reiterated an 'Overweight' rating, citing fundamental momentum and a year of inflection for Certara despite industry challenges [3]. - Leerink upgraded Certara from 'Market Perform' to 'Outperform' while keeping the price target at $13, attributing this to the company's leadership in the biosimulation market and viewing the previous selloff as an overreaction [4]. Group 2: Company Overview - Certara focuses on providing software and technology-enabled services for drug developers, including modeling, decision analytics, clinical pharmacology, complex biologics, and regulatory strategy solutions [5].

Core Viewpoint - The article discusses 14 oversold value stocks that present investment opportunities due to significant price declines and favorable analyst sentiment, amidst a broader market context of volatility and potential recovery [5][7]. Market Overview - U.S. equity markets are expected to remain strong in 2026, with a target for the S&P 500 set at 7,700 based on technical indicators rather than fundamentals [2]. - Market breadth is improving, with smaller stocks like the Russell 2000 breaking through resistance levels [3]. - Morgan Stanley projects a 14% rise in the S&P 500 over the next 12 months, driven by earnings growth, anticipated Federal Reserve rate cuts, and corporate tax reductions [3]. Recent Market Activity - A sharp selloff occurred in the business software sector, with the S&P 500 software and services index declining for seven consecutive sessions, now trading 21% below its 200-day moving average, marking the deepest drop since June 2022 [4][5]. - This selloff has pushed several value stocks into oversold territory, creating potential investment opportunities [5]. Methodology for Stock Selection - The selection of the 14 oversold value stocks was based on criteria including a forward P/E below 16, a three-month share price decline of 20%-40%, and a Relative Strength Index below 40 [7]. - Stocks were also evaluated for their potential to rebound, with significant analyst coverage considered [7]. Hedge Fund Sentiment - Stocks were ranked based on the number of hedge funds holding each stock as of Q3 2025, indicating bullish sentiment from institutional investors [8]. - Research suggests that imitating top hedge fund stock picks can lead to market outperformance [9]. Individual Stock Highlights - **eToro Group Ltd. (NASDAQ:ETOR)**: Experienced a 22.94% decline over three months, with a 103.5% upside potential and strong analyst sentiment [10]. Analysts from Goldman Sachs, Mizuho, and TD Cowen have adjusted price targets, reflecting mixed views on the stock's future [11][12][13]. - **Certara, Inc. (NASDAQ:CERT)**: Noted a 34.11% decline over three months, with a 57.70% upside potential and 60% analyst bullishness [15]. Analysts from KeyBanc and Leerink have provided insights on the stock's performance and future growth prospects [16][17]. - **Enovis Corporation (NYSE:ENOV)**: Faced a 27.31% decline over three months, with a 97.30% upside potential [19]. Analysts from Evercore ISI and BTIG have reiterated positive ratings, highlighting the company's revenue dynamics and market strategy [20][22].

Core Insights - The health care sector has identified oversold stocks, presenting potential investment opportunities in undervalued companies [1] - The Relative Strength Index (RSI) is a key momentum indicator used to assess stock performance, with an RSI below 30 indicating that a stock is considered oversold [1] Oversold Stocks List - Zai Lab Ltd – ADR (NASDAQ:ZLAB) is among the major oversold players in the health care sector [3] - Vivos Therapeutics Inc (NASDAQ:VVOS) is also listed as an oversold stock [3] - Certara Inc (NASDAQ:CERT) is included in the list of oversold companies [3]

Core Insights - The health care sector has identified oversold stocks, presenting potential investment opportunities in undervalued companies [1] - The Relative Strength Index (RSI) is a key momentum indicator used to assess stock performance, with an RSI below 30 indicating that a stock is considered oversold [1] Oversold Stocks - Zai Lab Ltd – ADR (NASDAQ:ZLAB) is listed as one of the major oversold players in the health care sector [3] - Vivos Therapeutics Inc (NASDAQ:VVOS) is also identified as an oversold stock with an RSI near or below 30 [3] - Certara Inc (NASDAQ:CERT) is included in the list of oversold stocks, indicating potential for recovery [3]

Core Viewpoint - Certara, Inc. will release its financial results for Q4 and the full year of 2025 on February 26, 2026, before market open, followed by a conference call at 8:30 AM ET to discuss these results [1]. Group 1 - The financial results announcement is scheduled for February 26, 2026, before market open [1]. - A conference call will be hosted by company management at 8:30 AM ET to discuss the financial results [1]. - Investors interested in the conference call must register online, with a recommendation to do so at least one day in advance [2]. Group 2 - Certara is a global leader in model-informed drug development, utilizing biosimulation software and technology to enhance drug discovery and development [3]. - The company serves over 2,600 clients, including biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries [3].

Group 1 - The article does not provide any relevant content regarding the company or industry [1]

Market Overview - U.S. equity markets in Q4 2025 were influenced by optimism regarding potential monetary easing and caution related to economic growth and valuations [1] - Early gains were driven by strong AI-related earnings and a rate cut by the US Federal Reserve in October, but sentiment cooled later due to mixed signals from the Fed [1] - Large caps rose 17.4% for the year and 2.4% in the quarter, while small caps gained 12.8% for the year and 2.2% in the quarter [1] - Value stocks outperformed growth stocks, returning 3.3% versus 1.2% for the quarter [1] Fund Performance - Meridian Growth Fund delivered a return of -0.39% (net) in the quarter, underperforming the Russell 2500 Growth Index's return of 0.33% [1] - The firm is monitoring factors affecting market returns, including changes in monetary policy and the sustainability of AI investments due to high valuations among hyperscalers [1] - The focus remains on high-quality businesses with strong competitive advantages, solid balance sheets, and clear sustainable earnings growth [1] Company Spotlight: Certara, Inc. - Certara, Inc. (NASDAQ:CERT) was highlighted as a leading relative detractor for the Meridian Growth Fund [2] - Certara offers software products and technology-enabled services for bio-simulation, with shares trading between $8.03 and $15.69 over the past 52 weeks, closing at $10.11 on January 26, 2026 [2] - The company experienced a one-month return of 14.11% but lost 16.65% of its value over the last three months, with a market capitalization of $1.61 billion [2] Certara's Business Dynamics - Certara develops software and services that support drug development through biosimulation, with a majority of recent FDA-approved drugs utilizing its solutions [3] - The company underperformed in the quarter due to weaker-than-expected service bookings, leading to a slight reduction in guidance [3] - With a new CEO adopting a more commercially focused strategy and potential divestiture of a non-core business segment, Certara is positioned to transform into a more focused growth company [3]

Core Viewpoint - Cerrado Gold Inc. is hosting a management conference call to discuss an unfavorable opinion regarding the environmental impact assessment for the Lago Salgada Project in Portugal, scheduled for January 26, 2026 [1]. Company Overview - Cerrado Gold is a Toronto-based gold production, development, and exploration company, owning 100% of the Minera Don Nicolás and Las Calandrias mine in Argentina [3]. - The company holds an 80% interest in the Lagoa Salgada VMS project in Portugal and is developing the Mont Sorcier Iron project in Canada [3]. Operations in Argentina - In Argentina, the company is optimizing asset value at the Minera Don Nicolás operation and increasing production at the Las Calandrias heap leach project [4]. - An extensive exploration campaign is ongoing to unlock potential resources in the Deseado Massif region [4]. Operations in Portugal - The Lagoa Salgada project is a high-grade polymetallic project located on the Iberian Pyrite Belt, with mineralization including zinc, copper, lead, tin, silver, and gold [5]. - The project covers a large 7,209-hectare property concession, offering significant exploration and development opportunities due to its proximity to Lisbon and existing infrastructure [5]. Operations in Canada - The Mont Sorcier project is a high-purity, high-grade Direct Reduced Iron project, with potential for long mine life and low operating costs [6]. - The project supports the transition of steel producers from blast furnaces to electric arc furnaces, aiding in industry decarbonization and sustainable development goals [6].

Core Viewpoint - Cerrado Gold Inc. is facing challenges regarding the environmental impact assessment for its Lago Salgada Project in Portugal, prompting a management conference call to discuss the situation and next steps [1][2]. Company Overview - Cerrado Gold is a Toronto-based gold production, development, and exploration company, owning 100% of the Minera Don Nicolás and Las Calandrias mines in Argentina [2]. - The company holds an 80% interest in the Lagoa Salgada VMS project in Portugal and is also developing the Mont Sorcier Iron project in Canada [2][5]. Project Details - The Lagoa Salgada project is located on the Iberian Pyrite Belt and is characterized by high-grade polymetallic mineralization, including zinc, copper, lead, tin, silver, and gold [4]. - The project covers a large area of 7,209 hectares and is situated 80 km from Lisbon, benefiting from excellent infrastructure [4]. - The Mont Sorcier project aims to produce high-purity, high-grade Direct Reduced Iron, which supports the transition of steel production towards more sustainable methods [5]. Operational Strategy - In Argentina, the company is focused on optimizing operations at Minera Don Nicolás and increasing production at the Las Calandrias heap leach project [3]. - An extensive exploration campaign is underway to unlock additional resources in the Deseado Massif region [3].